<DOC>
	<DOCNO>NCT01161121</DOCNO>
	<brief_summary>The purpose study determine regadenoson safe effective adenosine use cardiac catheterization lab measurement coronary flow reserve fractional flow reserve . The study hypothesis assessment Fractional Flow Reserve ( FFR ) catheterization lab perform equivalent accuracy hyperemia induce IV Regadenoson compare IV Adenosine without compromise patient safety .</brief_summary>
	<brief_title>Regadenoson Achieve Maximal Hyperemia Fractional Flow Reserve Catheterization Lab</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hyperemia</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>male female patient great 18 year old ( If female , pt . must postmenopausal , surgically sterile , nonpregnant determine negative urine serum BHCG pregnancy test within 24 hour prior enrollment . Provided write consent approve Institutional Review Board provide HIPAA authorization Have least one coronary stenosis ( great equal 40 % less 70 &amp; narrow visual inspection ) technically accessible coronary artery pressure wire may introduce . ST elevation myocardial infarction Cardiogenic shock Pregnancy Total vessel occlusion Extremely tortuous coronary artery Second third degree heart block without pacemaker Severe chronic obstructive pulmonary disease active bronchospasm Less age 18 year Have receive theophylline , aminophylline , pentoxifylline dipyridamole within 12 hour FFR measurement . Has severe 3 vessel disease define &gt; 80 % luminal narrowing visual inspection Known hypersensitivity adenosine regadenoson Recent uncontrolled ventricular arrhythmia History great Type I atrioventricular block , symptomatic resting bradycardia , sick sinus syndrome ( without permanent pacemaker ) History heart transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Fractional flow reserve</keyword>
	<keyword>adenosine</keyword>
	<keyword>regadenoson</keyword>
</DOC>